These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37218093)

  • 1. Untargeted metabolomics reveals hepatic metabolic disorder in the BTBR mouse model of autism and the significant role of liver in autism.
    Cao C; Wang D; Zou M; Sun C; Wu L
    Cell Biochem Funct; 2023 Jul; 41(5):553-563. PubMed ID: 37218093
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Untargeted Metabolomic Analysis Reveals the Metabolic Disturbances and Exacerbation of Oxidative Stress in the Cerebral Cortex of a BTBR Mouse Model of Autism.
    Cao C; Li Q; Chen Y; Zou M; Sun C; Li X; Wu L
    J Mol Neurosci; 2023 Jan; 73(1):15-27. PubMed ID: 36574152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human-derived fecal microbiota transplantation alleviates social deficits of the BTBR mouse model of autism through a potential mechanism involving vitamin B
    Zheng L; Jiao Y; Zhong H; Tan Y; Yin Y; Liu Y; Liu D; Wu M; Wang G; Huang J; Wang P; Qin M; Wang M; Xiao Y; Lv T; Luo Y; Hu H; Hou S-T; Kui L
    mSystems; 2024 Jun; 9(6):e0025724. PubMed ID: 38780265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epothilone D Modulates Autism-like Behaviors in the BTBR Mouse Model of Autism Spectrum Disorder.
    Zhao M; Chang Q; Yang H; Wang M; Liu Y; Lv N; Lei Q; Wei H
    Neuroscience; 2022 May; 490():171-181. PubMed ID: 35227832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic Alterations in a BTBR T + Itpr3tf/J Mouse Model of Autism and Improvement Using Melatonin via Mitigation Oxidative Stress, Inflammation and Ferroptosis.
    Rezzani R; Gianò M; Pinto D; Rinaldi F; van Noorden CJF; Favero G
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential Expression of Hippocampal Circular RNAs in the BTBR Mouse Model for Autism Spectrum Disorder.
    Gasparini S; Del Vecchio G; Gioiosa S; Flati T; Castrignano T; Legnini I; Licursi V; Ricceri L; Scattoni ML; Rinaldi A; Presutti C; Mannironi C
    Mol Neurobiol; 2020 May; 57(5):2301-2313. PubMed ID: 32020500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypothalamic TrkB.FL overexpression improves metabolic outcomes in the BTBR mouse model of autism.
    Anderson JM; Boardman AA; Bates R; Zou X; Huang W; Cao L
    PLoS One; 2023; 18(3):e0282566. PubMed ID: 36893171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Environmental enrichment improves metabolic and behavioral health in the BTBR mouse model of autism.
    Queen NJ; Boardman AA; Patel RS; Siu JJ; Mo X; Cao L
    Psychoneuroendocrinology; 2020 Jan; 111():104476. PubMed ID: 31648110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nrf2 activator, sulforaphane ameliorates autism-like symptoms through suppression of Th17 related signaling and rectification of oxidant-antioxidant imbalance in periphery and brain of BTBR T+tf/J mice.
    Nadeem A; Ahmad SF; Al-Harbi NO; Attia SM; Bakheet SA; Ibrahim KE; Alqahtani F; Alqinyah M
    Behav Brain Res; 2019 May; 364():213-224. PubMed ID: 30790585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligustilide inhibits Purkinje cell ferritinophagy via the ULK1/NCOA4 pathway to attenuate valproic acid-induced autistic features.
    Zhou L; Jiang P; Zhao L; Fei X; Tang Y; Luo Y; Gong H; Wang X; Li X; Li S; Zhang C; Yang H; Fan X
    Phytomedicine; 2024 Apr; 126():155443. PubMed ID: 38394737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Supplementation with selenium attenuates autism-like behaviors and improves oxidative stress, inflammation and related gene expression in an autism disease model.
    Wu H; Zhao G; Liu S; Zhang Q; Wang P; Cao Y; Wu L
    J Nutr Biochem; 2022 Sep; 107():109034. PubMed ID: 35500829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lead (Pb) exposure exacerbates behavioral and immune abnormalities by upregulating Th17 and NF-κB-related signaling in BTBR T
    Almutairi MM; Nadeem A; Ansari MA; Bakheet SA; Attia SM; Albekairi TH; Alhosaini K; Algahtani M; Alsaad AMS; Al-Mazroua HA; Ahmad SF
    Neurotoxicology; 2022 Jul; 91():340-348. PubMed ID: 35760230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic-Based Approach Reveals the Involvement of Apolipoprotein A-I in Related Phenotypes of Autism Spectrum Disorder in the BTBR Mouse Model.
    Li Q; Shi Y; Li X; Yang Y; Zhang X; Xu L; Ma Z; Wang J; Fan L; Wu L
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serotonergic circuit dysregulation underlying autism-related phenotypes in BTBR mouse model of autism.
    Higuchi Y; Tada T; Nakachi T; Arakawa H
    Neuropharmacology; 2023 Oct; 237():109634. PubMed ID: 37301467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Icariin alleviates autistic-like behavior, hippocampal inflammation and vGlut1 expression in adult BTBR mice.
    Jiang P; Zhou L; Du Z; Zhao L; Tang Y; Fei X; Wang L; Li D; Li S; Yang H; Fan X; Liao H
    Behav Brain Res; 2023 May; 445():114384. PubMed ID: 36889463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minocycline improves autism-related behaviors by modulating microglia polarization in a mouse model of autism.
    Luo Y; Lv K; Du Z; Zhang D; Chen M; Luo J; Wang L; Liu T; Gong H; Fan X
    Int Immunopharmacol; 2023 Sep; 122():110594. PubMed ID: 37441807
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid and neurosteroid dysregulation in an animal model of autism, BTBR mice.
    Frye CA; Llaneza DC
    Physiol Behav; 2010 Jun; 100(3):264-7. PubMed ID: 20298706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ketogenic diet leads to O-GlcNAc modification in the BTBR
    Newell C; Johnsen VL; Yee NC; Xu WJ; Klein MS; Khan A; Rho JM; Shearer J
    Biochim Biophys Acta Mol Basis Dis; 2017 Sep; 1863(9):2274-2281. PubMed ID: 28502704
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Stat3 inhibitor, S3I-201, downregulates lymphocyte activation markers, chemokine receptors, and inflammatory cytokines in the BTBR T
    Ahmad SF; Ansari MA; Nadeem A; Bakheet SA; Alanazi AZ; Alsanea S; As Sobeai HM; Almutairi MM; Mahmood HM; Attia SM
    Brain Res Bull; 2019 Oct; 152():27-34. PubMed ID: 31299319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development, phenotypes of immune cells in BTBR T
    Uddin MN; Yao Y; Manley K; Lawrence DA
    Cell Immunol; 2020 Dec; 358():104223. PubMed ID: 33137646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.